期刊文献+

HIV感染者抗病毒治疗及性行为情况凋查 被引量:8

Investigation on HAART of HIV infection and sexual behaviors
下载PDF
导出
摘要 目的研究河南省高效抗逆转录病毒治疗效果和耐药情况,为防止耐药株流行提供理论依据。方法采用问卷调查方法,了解人类免疫缺陷病毒(HIV)感染者人口学、治疗和漏服情况及安全套使用情况,RT-PCR和套式PCR扩增HIV pol区基因,双脱氧法测定逆转录酶和蛋白酶基因序列,与国际耐药数据库比对辨别耐药变异。结果本次调查人群文化程度较低,家庭经济条件差;治疗组病毒载量显著低于未治疗组(P<0.01);安全套使用率低(23.1%);服药依从性较差(72.2%):治疗人群中发现6例存在耐药突变,未治疗感染者发现1例存在耐药变异。结论抗病毒治疗初期疗效显著,耐药变异率低,但漏服和较低的安全套使用率将导致耐药变异快速产生和流行,应加强用药督导和安全套普及。 Objective To prevent the prevalence of drug resistance viruses, drug resistance muations of HIV- 1 and curative effect after taking HAART among HIV - 1 infected individuals in Henan province were analyzed. Methods Patients' information about demology, treatment, compliance and condom were acquired from questionnaires, amplified HIV-1 pol gene by RT-PCR and nest-PCR, sequenced reverse trascraptase (RT) and protease regions and compared with sequence in Stanford HIV drug resistance sequence database. Results The education level of patients and the income investigated was lower; The viral load in treated patients was obviously lower than that in untreated patients (P 〈 0.01 ) ; Lower frequency in condom use (23.1%) ;frequency of patients who followed doctors was lower(72.2 % );six drug resistance mutations were found in six treated patients, and one drug resistance mutations were found in untreated patients. Conclusion The curative effect was notable in early period of HAART, The frequency of drug mutation was lower, but lower condom use and disobedience of taking drug would make drug mutations occur and spread. To prevent the prevalence of drug resistance viruses, monitoring the drug taking and generalizing the condom were necessary.
出处 《中国公共卫生》 CAS CSCD 北大核心 2007年第9期1055-1056,共2页 Chinese Journal of Public Health
基金 卫生部艾滋病防治研究项目(WA2003-01) 辽宁省教育厅科技攻关计划(2012215112) 辽宁省优秀青年科研人才培养资金资助项目(3040011)
关键词 人类免疫缺陷病毒(HIV) 抗病毒治疗 耐药 依从性 HIV HAART drug resistance compliance
  • 相关文献

参考文献5

  • 1Shafer R W. Genotypic testing for immunodeficiency virus type 1 drug resistance[J]. Clin Microbiol Rev, 2002, 15:247-277.
  • 2Harzic M, Pellegrin I, Deveau C, et al. Genotypic drug resistance during HIV-1 primary infection in France (1996 - 1999) :frequency and response to treatment[J ]. AIDS, 2002, 16:793-796.
  • 3Nannini EC, Han X, O'Brien W A, et al. Genotypic HIV-1 drug resistance testing in antiretroviral-naive subujects in Houston, Texan [ J ]. J Acqyir Immune Defic Syndr, 2002, 29 : 317 - 796.
  • 4Durant J, Clevenbergh P, Halfon P, et al. Drug resistance genotyging in HIV-1 therapy: the VIRADAPT randomised controlled trial [J]. Lancet, 1999, 353:2195 - 2199.
  • 5张旻,尚红,韩晓旭,张子宁,王亚男,刘宝贵,李秀金,刘静,姜拥军,王树祥,张岩,赵斌.中国东北地区未经抗病毒治疗的HIV/AIDS患者HIV毒株的耐药基因变异研究[J].中华微生物学和免疫学杂志,2004,24(11):850-854. 被引量:34

二级参考文献15

  • 1Dealaney S, Zheng N, McQueen P. Emergency of drug-resistant HIV-1 strains from patients on long term ddI therapy. 12th World AIDS Conference. Geneva, 1998, 41: 224.
  • 2Grant RM, Kahn JO, Warmerdam M, et al. Transmission and transmissibility of drug resistant HIV-1. Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, Washington, 2002, 368.
  • 3Durant JCP, Clevenbergh P, Halfon P, et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomized controlled trial. Lancet, 1999, 353: 2195-2199.
  • 4Clevenbergh P, Durant JCP, Halfon P, et al. Persisting long-term benefit of antiretroviral genotypic guided treatment for HIV-infected patients failing on HAART: the VIRADAPT study, week 48 follow up. Antiviral Ther, 1999, 4(Suppl.1): 42.
  • 5Hirsch MS, Conway B, D′Aquila RT, et al. Antiretroviral drug resistance testing in adults with HIV infection. JAMA, 1998, 279: 1984-1991.
  • 6Vandamme AM, Van Laethem K, De Clercq E, et al. Managing resistance to anti-HIV drugs: an important consideration for effective disease management. Drugs, 1999, 57: 337-361.
  • 7Brideiro PA, Brindeiro RM, Mortensen C, et al. Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. J Clin Microbiol, 2002, 40(12): 4512-4519.
  • 8Caride E, Hertogs K, Larder B, et al. Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virus Genes, 2001
  • 9Shao YM, Su L, Sun XH, et al. Molecular epidemiology of HIV infectionin China. Paper presented at: XII International Conference on AIDS, Geneva. 1998, 6.
  • 10Shao Y. AIDS in south and southeast asia. HIV/AIDS: perspective on China. AIDS Patient Care STD, 2001, 15: 431-432.

共引文献33

同被引文献106

引证文献8

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部